H-1B sponsors › D › DeepNephro, Inc.
Does DeepNephro, Inc. sponsor H-1B visas?
U.S. Department of Labor filings, Oct 2025 – Jun 2026.
Roles and salaries on DeepNephro, Inc.'s H-1B filings
| Job title | Filings | Median wage | Middle 50% |
|---|---|---|---|
| Principal Scientist | 2 | $110,000 | $110,000 – $110,000 |
Where DeepNephro, Inc.'s H-1B roles are based
- Los Angeles, CA — 2
Other H-1B sponsors for Principal Scientists
| Employer | Filings for this role | Median wage |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 21 | $164,000 |
| Bristol-Myers Squibb Company | 8 | $163,178 |
| Amgen Inc. | 6 | $161,000 |
| GlaxoSmithKline LLC | 5 | $97,500 |
| Cytiva US LLC | 3 | $130,543 |
| ELC Beauty LLC | 2 | $126,250 |
| Eurofins Professional Scientific Services Mid-Atlantic, LLC. | 2 | $71,760 |
| Janssen Research & Development, LLC | 2 | $173,800 |
All 34 sponsors for Principal Scientists →
Other H-1B sponsors in Los Angeles, CA
All 850 sponsors in Los Angeles, CA →
Questions
Does DeepNephro, Inc. sponsor H-1B visas?
Rarely. DeepNephro, Inc. has filed a small number of H-1B applications: 2 certified H-1B labor condition applications (LCAs) in Department of Labor data for Oct 2025 – Jun 2026. An LCA is filed before an H-1B petition, so it is a strong sign of sponsorship but not a guarantee.
How much does DeepNephro, Inc. pay H-1B workers?
Median wages stated on DeepNephro, Inc.'s certified LCAs range from $110,000 to $110,000 a year across its most common roles; Principal Scientist had a median of $110,000.
Which roles does DeepNephro, Inc. sponsor?
The most frequent job titles on DeepNephro, Inc.'s LCAs are Principal Scientist.
Source: U.S. Department of Labor, Office of Foreign Labor Certification — LCA disclosure data, Oct 2025 – Jun 2026. An LCA (Labor Condition Application) is the step an employer files before an H-1B petition; a certified LCA is not a visa approval, and past filings don't guarantee an employer will sponsor you. Salaries are the wages employers stated on the LCAs. Offerbound is not affiliated with the companies listed.